
REMAP-CAP to Partner With Eisai on Innovative Trial to Combat COVID
GCAR, Eisai and UPMC, on Behalf of REMAP-CAP Investigator Network, Announce Eritoran’s Inclusion in REMAP-COVID, An Adaptive Clinical Trial to Test Interventions for Patients With […]
